| [1] |
Balk RA. Severe sepsis and septic shock. Definitions, epidemiology, and clinical manifestations[J]. Crit Care Clin, 2000, 16 （2）: 179-192.
|
| [2] |
Hotchkiss RS,Karl IE. The pathophysiology and treatment of sepsis[J]. N Engl J Med, 2003, 348 （2）: 138-150.
|
| [3] |
Terblanche M,Almog Y,Rosenson RS, et al. Statins and sepsis: multiple modifications at multiple levels[J]. Lancet Infect Dis, 2007, 7 （5）: 358-368.
|
| [4] |
Jasinska M,Owczarek J,Orszulak-Michalak D. Statins: a new insight into their mechanisms of action and consequent pleiotropic effects[J]. Pharmacol Rep, 2007, 59 （5）: 483-499.
|
| [5] |
Kouroumichakis I,Papanas N,Proikaki S, et al. Statins in prevention and treatment of severe sepsis and septic shock[J]. Eur J Intern Med, 2011, 22 （2）: 125-133.
|
| [6] |
Yang KC,Chien JY,Tseng WK, et al. Statins do not improve short-term survival in an oriental population with sepsis[J]. Am J Emerg Med, 2007, 25 （5）: 494-501.
|
| [7] |
American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis[J]. Crit Care Med, 1992, 20 （6）: 864-874.
|
| [8] |
Mortensen EM,Pugh MJ,Copeland LA, et al. Impact of statins and angiotensin-converting enzyme inhibitors on mortality of subjects hospitalised with pneumonia[J]. Eur Respir J, 2008, 31 （3）: 611-617.
|
| [9] |
Fogerty MD,Efron D,Morandi A, et al. Effect of preinjury statin use on mortality and septic shock in elderly burn patients[J]. J Trauma, 2010, 69 （1）: 99-103.
|
| [10] |
Calisto KL,Carvalho Bde M,Ropelle ER, et al. Atorvastatin improves survival in septic rats: effect on tissue inflammatory pathway and on insulin signaling[J]. PLoS One, 2010, 5 （12）: e14232.
|
| [11] |
Merx MW,Liehn EA,Graf J, et al. Statin treatment after onset of sepsis in a murine model improves survival[J]. Circulation, 2005, 112 （1）: 117-124.
|
| [12] |
Ando H,Takamura T,Ota T, et al. Cerivastatin improves survival of mice with lipopolysaccharide-induced sepsis[J]. J Pharmacol Exp Ther, 2000, 294 （3）: 1043-1046.
|
| [13] |
Merx MW,Liehn EA,Janssens U, et al. HMG-CoA reductase inhibitor simvastatin profoundly improves survival in a murine model of sepsis[J]. Circulation, 2004, 109 （21）: 2560-2565.
|
| [14] |
Chaudhry MZ,Wang JH,Blankson S, et al. Statin (cerivastatin) protects mice against sepsis-related death via reduced proinflammatory cytokines and enhanced bacterial clearance[J]. Surgical Infections, 2008, 9 （2）: 183-194.
|
| [15] |
Subramani J,Kathirvel K,Leo MD, et al. Atorvastatin restores the impaired vascular endothelium-dependent relaxations mediated by nitric oxide and endothelium-derived hyperpolarizing factors but not hypotension in sepsis[J]. J Cardiovasc Pharmacol, 2009, 54 （6）: 526-534.
|
| [16] |
Boyd AR,Hinojosa CA,Rodriguez PJ, et al. Impact of oral simvastatin therapy on acute lung injury in mice during pneumococcal pneumonia[J]. BMC Microbiol, 2012, 12:73.
|
| [17] |
Durant R,Klouche K,Delbosc S, et al. Superoxide anion overproduction in sepsis: effects of vitamin e and simvastatin[J]. Shock, 2004, 22 （1）: 34-39.
|
| [18] |
Niessner A,Steiner S,Speidl WS, et al. Simvastatin suppresses endotoxin-induced upregulation of toll-like receptors 4 and 2 in vivo[J]. Atherosclerosis, 2006, 189 （2）: 408-413.
|
| [19] |
Novack V,Eisinger M,Frenkel A, et al. The effects of statin therapy on inflammatory cytokines in patients with bacterial infections: a randomized double-blind placebo controlled clinical trial[J]. Intensive Care Med, 2009, 35 （7）: 1255-1260.
|
| [20] |
Kruger PS,Harward ML,Jones MA, et al. Continuation of statin therapy in patients with presumed infection: a randomized controlled trial[J]. Am J Respir Crit Care Med, 2011, 183 （6）: 774-781.
|